Work

Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions.

Year: 2021
Type: article
Abstract: Once-daily topical application of FMX103 1.5% did not lead to appreciable systemic exposure or accumulation of minocycline, suggesting that it is a viable treatment option for papulopustular rosacea.
Authors: Terry M Jones, Iain Stuart
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: green
OpenAlex ID: W3156654460
FWCI: 0.903
Cites: 7
Cited by: 6
Related to: 10